UBS Group Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG) had its target price hoisted by UBS Group from $500.00 to $560.00 in a research note published on Monday morning. They currently have a neutral rating on the medical equipment provider’s stock.

Several other equities analysts have also recently commented on the stock. Robert W. Baird raised their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Bernstein Bank increased their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday. Citigroup boosted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $572.71 on Monday. The company’s 50-day simple moving average is $548.70 and its 200-day simple moving average is $507.04. Intuitive Surgical has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market capitalization of $203.99 billion, a PE ratio of 92.08, a P/E/G ratio of 5.19 and a beta of 1.39.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 28,843 shares of company stock valued at $15,357,560. Insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

Large investors have recently bought and sold shares of the company. AQR Capital Management LLC raised its holdings in Intuitive Surgical by 12.6% during the second quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider’s stock worth $18,958,000 after purchasing an additional 4,775 shares in the last quarter. Creative Planning increased its position in Intuitive Surgical by 9.8% during the 2nd quarter. Creative Planning now owns 63,039 shares of the medical equipment provider’s stock worth $28,043,000 after purchasing an additional 5,629 shares during the period. NewEdge Advisors LLC raised its stake in shares of Intuitive Surgical by 8.2% during the 2nd quarter. NewEdge Advisors LLC now owns 13,825 shares of the medical equipment provider’s stock worth $6,150,000 after buying an additional 1,044 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Intuitive Surgical by 2.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 20,458 shares of the medical equipment provider’s stock valued at $9,100,000 after buying an additional 411 shares during the period. Finally, Wellington Wealth Strategies LLC. purchased a new stake in shares of Intuitive Surgical in the second quarter valued at approximately $241,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.